UPenn Perelman School of Medicine: "Dual-Target" Cell Therapy Appears to Shrink Brain Tumors, Penn Medicine Research Finds
March 14, 2024
March 14, 2024
UNIVERSITY CITY, Pennsylvania, March 14 (TNSres) -- The University of Pennsylvania's Perelman School of Medicine issued the following news release:
* * *
Early trial results from six patients with recurrent glioblastoma may be a promising step towards developing cell therapies for solid tumors
* * *
Targeting two brain tumor-associated proteins--rather than one--with CAR T cell therapy shows promise as a strategy for reducing solid tumor g . . .
* * *
Early trial results from six patients with recurrent glioblastoma may be a promising step towards developing cell therapies for solid tumors
* * *
Targeting two brain tumor-associated proteins--rather than one--with CAR T cell therapy shows promise as a strategy for reducing solid tumor g . . .